{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:41:39Z","timestamp":1792230099693,"version":"4.4.0"},"reference-count":131,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974096"],"award-info":[{"award-number":["81974096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Chronic kidney disease (CKD) is a common public health concern. The global burden of CKD is increasing due to the high morbidity and mortality associated with it, indicating the shortcomings of therapeutic drugs at present. Renal fibrosis is the common pathology of CKD, which is characterized by glomerulosclerosis, renal tubular atrophy, and renal interstitial fibrosis. Natural hirudin is an active ingredient extracted from Hirudo medicinalis, which has been found to be the strongest natural specific inhibitor of thrombin. Evidence based on pharmacological data has shown that hirudin has important protective effects in CKD against diabetic nephrology, nephrotic syndrome, and renal interstitial fibrosis. The mechanisms of hirudin in treating CKD are mainly related to inhibiting the inflammatory response, preventing apoptosis of intrinsic renal cells, and inhibiting the interactions between thrombin and protease-activated receptors. In this review, we summarize the function and beneficial properties of hirudin for the treatment of CKD, and its underlying mechanisms.<\/jats:p>","DOI":"10.3390\/molecules29051029","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T11:52:55Z","timestamp":1709034775000},"page":"1029","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hirudin in the Treatment of Chronic Kidney Disease"],"prefix":"10.3390","volume":"29","author":[{"given":"Sai-Ji","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3565-8024","authenticated-orcid":false,"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-physiol-031620-091656","article-title":"Function of Renal Nerves in Kidney Physiology and Pathophysiology","volume":"83","author":"Osborn","year":"2021","journal-title":"Annu. Rev. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic Kidney Disease Diagnosis and Management: A Review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrneph.2016.163","article-title":"The Global Burden of Chronic Kidney Disease: Estimates, Variability and Pitfalls","volume":"13","author":"Glassock","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ki.2015.230","article-title":"A Systematic Analysis of Worldwide Population-Based Data on the Global Burden of Chronic Kidney Disease in 2010","volume":"88","author":"Mills","year":"2015","journal-title":"Kidney Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1681\/ASN.2015050542","article-title":"CKD Prevalence Varies across the European General Population","volume":"27","author":"Stel","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting Life Expectancy, Years of Life Lost, and All-Cause and Cause-Specific Mortality for 250 Causes of Death: Reference and Alternative Scenarios for 2016\u201340 for 195 Countries and Territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated Glomerular Filtration Rate and Albuminuria for Prediction of Cardiovascular Outcomes: A Collaborative Meta-Analysis of Individual Participant Data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower Estimated GFR and Higher Albuminuria Are Associated with Adverse Kidney Outcomes. A Collaborative Meta-Analysis of General and High-Risk Population Cohorts","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/ckj\/sfab070","article-title":"Fighting the Unbearable Lightness of Neglecting Kidney Health: The Decade of the Kidney","volume":"14","author":"Vanholder","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ki.2011.368","article-title":"The Contribution of Chronic Kidney Disease to the Global Burden of Major Noncommunicable Diseases","volume":"80","author":"Couser","year":"2011","journal-title":"Kidney Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.trsl.2020.09.001","article-title":"Challenges of Reducing Protein-Bound Uremic Toxin Levels in Chronic Kidney Disease and End Stage Renal Disease","volume":"229","author":"Faria","year":"2021","journal-title":"Transl. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the Progression of Chronic Kidney Disease","volume":"16","author":"Lamas","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/bcp.12195","article-title":"Novel Drugs and Intervention Strategies for the Treatment of Chronic Kidney Disease","volume":"76","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural Products: A Continuing Source of Novel Drug Leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochim. Biophys. Acta BBA Gen. Subj."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.phymed.2018.09.182","article-title":"Natural Products for the Prevention and Treatment of Kidney Disease","volume":"50","author":"Chen","year":"2018","journal-title":"Phytomedicine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7895935","DOI":"10.1155\/2016\/7895935","article-title":"Chinese Medicinal Leech: Ethnopharmacology, Phytochemistry, and Pharmacological Activities","volume":"2016","author":"Dong","year":"2016","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"27448","DOI":"10.1039\/C8RA04358B","article-title":"Combined Systems Pharmacology and Fecal Metabonomics to Study the Biomarkers and Therapeutic Mechanism of Type 2 Diabetic Nephropathy Treated with Astragalus and Leech","volume":"8","author":"Chen","year":"2018","journal-title":"RSC Adv."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1021\/bi00364a025","article-title":"Kinetics of the Inhibition of Thrombin by Hirudin","volume":"25","author":"Stone","year":"1986","journal-title":"Biochemistry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00436-016-5294-9","article-title":"Hirudins and Hirudin-like Factors in Hirudinidae: Implications for Function and Phylogenetic Relationships","volume":"116","author":"Haase","year":"2017","journal-title":"Parasitol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/01.CIR.88.5.2015","article-title":"Recombinant Hirudin in Patients with Chronic, Stable Coronary Artery Disease. Safety, Half-Life, and Effect on Coagulation Parameters","volume":"88","author":"Zoldhelyi","year":"1993","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2165\/00019053-200119050-00012","article-title":"Cost Effectiveness of Desirudin Compared with a Low Molecular Weight Heparin in the Prevention of Deep Vein Thrombosis after Total Hip Replacement Surgery","volume":"19","author":"Levin","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Peng, L., Pan, X., and Yin, G. (2015). Natural Hirudin Increases Rat Flap Viability by Anti-Inflammation via PARs\/P38\/NF-\u03baB Pathway. BioMed Res. Int., 2015.","DOI":"10.1155\/2015\/597264"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.9738\/CC171.1","article-title":"Effects of Natural and Recombinant Hirudin on VEGF Expression and Random Skin Flap Survival in a Venous Congested Rat Model","volume":"98","author":"Yingxin","year":"2013","journal-title":"Int. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1111\/bph.15384","article-title":"A Novel Oncotherapy Strategy: Direct Thrombin Inhibitors Suppress Progression, Dissemination and Spontaneous Metastasis in Non-small Cell Lung Cancer","volume":"179","author":"Zhao","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"146269","DOI":"10.1016\/j.gene.2022.146269","article-title":"The Role of Exosomal CDC6 in the Hirudin-Mediated Suppression of the Malignant Phenotype of Bladder Cancer Cells","volume":"821","author":"Shen","year":"2022","journal-title":"Gene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"108967","DOI":"10.1016\/j.intimp.2022.108967","article-title":"Hirudin Alleviates Acute Ischemic Stroke by Inhibiting NLRP3 Inflammasome-Mediated Neuroinflammation: In Vivo and in Vitro Approaches","volume":"110","author":"Li","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2019.03.001","article-title":"Therapeutic Effects of the rhSOD2-Hirudin Fusion Protein on Bleomycin-Induced Pulmonary Fibrosis in Mice","volume":"852","author":"Shen","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and Molecular Mechanisms of Renal Fibrosis","volume":"7","author":"Liu","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of Renal Fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"ref_31","unstructured":"Yuan, Q., Tan, R.J., and Liu, Y. (2019). Renal Fibrosis: Mechanisms and Therapies. Advances in Experimental Medicine and Biology, Springer."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"573557","DOI":"10.3389\/fphar.2020.573557","article-title":"Glomerular Endothelial Cells as Instigators of Glomerular Sclerotic Diseases","volume":"11","author":"Sol","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1159\/000127359","article-title":"The Regulation of Mesangial Cell Proliferation","volume":"108","author":"Hendry","year":"2008","journal-title":"Nephron Exp. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte Injury and Its Consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int."},{"key":"ref_35","unstructured":"Zhao, X.-C., Livingston, M.J., Liang, X.-L., and Dong, Z. (2019). Renal Fibrosis: Mechanisms and Therapies. Advances in Experimental Medicine and Biology, Springer."},{"key":"ref_36","unstructured":"Zhao, J.-H. (2019). Renal Fibrosis: Mechanisms and Therapies. Advances in Experimental Medicine and Biology, Springer."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lu, C.-C., Wang, G.-H., Lu, J., Chen, P.-P., Zhang, Y., Hu, Z.-B., and Ma, K.-L. (2019). Renal Fibrosis: Mechanisms and Therapies. Advances in Experimental Medicine and Biology, Springer.","DOI":"10.1007\/978-981-13-8871-2_31"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","article-title":"Renal Tubule Injury: A Driving Force toward Chronic Kidney Disease","volume":"93","author":"Liu","year":"2018","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00467-015-3169-4","article-title":"Tubular Atrophy in the Pathogenesis of Chronic Kidney Disease Progression","volume":"31","author":"Schelling","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Liu, B.-C., Tang, T.-T., and Lv, L.-L. (2019). Renal Fibrosis: Mechanisms and Therapies. Advances in Experimental Medicine and Biology, Springer.","DOI":"10.1007\/978-981-13-8871-2"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrneph.2014.246","article-title":"Diverse Origins of the Myofibroblast\u2014Implications for Kidney Fibrosis","volume":"11","author":"Falke","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000216256","article-title":"The History of Leeching and Hirudin","volume":"21","author":"Fields","year":"1991","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/bab.1632","article-title":"Noncoded Amino Acids in Protein Engineering: Structure\u2013Activity Relationship Studies of Hirudin\u2013Thrombin Interaction","volume":"65","author":"Acquasaliente","year":"2018","journal-title":"Biotechnol. Appl. Biochem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/02648725.2018.1506898","article-title":"Hirudin Variants Production by Genetic Engineered Microbial Factory","volume":"34","author":"Zhang","year":"2018","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"19818","DOI":"10.1038\/s41598-020-76715-w","article-title":"Cell-Free Synthesis of the Hirudin Variant 1 of the Blood-Sucking Leech Hirudo Medicinalis","volume":"10","author":"Lukas","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1538-7836.2012.04803.x","article-title":"Impact of Stage 3B Chronic Kidney Disease on Thrombosis and Bleeding Outcomes after Orthopedic Surgery in Patients Treated with Desirudin or Enoxaparin: Insights from a Randomized Trial","volume":"10","author":"Shorr","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3389\/fcvm.2022.821322","article-title":"Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study","volume":"9","author":"Peng","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Mongirdien\u0117, A., Liuiz\u0117, A., and Ka\u0161auskas, A. (2023). Novel Knowledge about Molecular Mechanisms of Heparin-Induced Thrombocytopenia Type II and Treatment Targets. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098217"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Montinari, M.R., and Minelli, S. (2022). From Ancient Leech to Direct Thrombin Inhibitors and beyond: New from Old. Biomed. Pharmacother., 149.","DOI":"10.1016\/j.biopha.2022.112878"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Markwardt, F. (1957). Die Isolierung und Chemische Charakterisierung des Hirudins, Walter de Gruyter.","DOI":"10.1515\/bchm2.1957.308.1.147"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2007-1002593","article-title":"Isolation and Characterization of Hirudin from Hirudo medicinalis","volume":"17","author":"Walsmann","year":"1991","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2002-35293","article-title":"Pharmacology of Recombinant Hirudin","volume":"28","author":"Nowak","year":"2002","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2007-1002603","article-title":"Pharmacokinetics of Hirudin","volume":"17","author":"Nowak","year":"1991","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0049-3848(91)90167-U","article-title":"Studies for Revealing a Possible Sensitization to Hirudin after Repeated Intravenous Injections in Baboons","volume":"61","author":"Bichler","year":"1991","journal-title":"Thromb. Res."},{"key":"ref_55","first-page":"2373","article-title":"Antihirudin Antibodies in Patients with Heparin-Induced Thrombocytopenia Treated with Lepirudin: Incidence, Effects on aPTT, and Clinical Relevance","volume":"96","author":"Eichler","year":"2000","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM199711063371901","article-title":"A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip Replacement","volume":"337","author":"Eriksson","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCRESAHA.112.264903","article-title":"Translational Success Stories: Development of Direct Thrombin Inhibitors","volume":"111","author":"Coppens","year":"2012","journal-title":"Circ. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and Prevention of Heparin-Induced Thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(96)91200-3","article-title":"Prevention of Deep-Vein Thrombosis after Total Hip Replacement: Direct Thrombin Inhibition with Recombinant Hirudin, CGP 39393","volume":"347","author":"Eriksson","year":"1996","journal-title":"Lancet"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1213\/ANE.0000000000002835","article-title":"Bivalirudin for Pediatric Procedural Anticoagulation: A Narrative Review","volume":"128","author":"Zaleski","year":"2019","journal-title":"Anesth. Analg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for Patients with Acute Coronary Syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a Glycoprotein IIb\/IIIa Inhibitor versus Bivalirudin Monotherapy and Paclitaxel-Eluting Stents versus Bare-Metal Stents in Acute Myocardial Infarction (HORIZONS-AMI): Final 3-Year Results from a Multicentre, Randomised Controlled Trial","volume":"377","author":"Stone","year":"2011","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.jvca.2010.12.015","article-title":"Update in Hematology: Heparin-Induced Thrombocytopenia and Bivalirudin","volume":"25","author":"Augoustides","year":"2011","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/phar.2859","article-title":"Anticoagulation Strategies in Patients with Extracorporeal Membrane Oxygenation: A Network Meta-analysis and Systematic Review","volume":"43","author":"Chen","year":"2023","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1237601","DOI":"10.3389\/fmed.2023.1237601","article-title":"Is It Time to Switch to Bivalirudin for ECMO Anticoagulation?","volume":"10","author":"Navaei","year":"2023","journal-title":"Front. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"7495629","DOI":"10.1155\/2019\/7495629","article-title":"The Signaling of Cellular Senescence in Diabetic Nephropathy","volume":"2019","author":"Xiong","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e6839","DOI":"10.5867\/medwave.2017.01.6839","article-title":"Pathophysiology of Diabetic Nephropathy: A Literature Review","volume":"17","author":"Letelier","year":"2017","journal-title":"Medwave"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","article-title":"Immunity and Inflammation in Diabetic Kidney Disease: Translating Mechanisms to Biomarkers and Treatment Targets","volume":"312","author":"Pichler","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"154013","DOI":"10.1016\/j.metabol.2019.154013","article-title":"Deletion of Smad3 Prevents Renal Fibrosis and Inflammation in Type 2 Diabetic Nephropathy","volume":"103","author":"Xu","year":"2020","journal-title":"Metabolism"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/ars.2016.6664","article-title":"Diabetes and Kidney Disease: Role of Oxidative Stress","volume":"25","author":"Jha","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"660757","DOI":"10.3389\/fphar.2021.660757","article-title":"Pharmacological Activities and Mechanisms of Hirudin and Its Derivatives-a Review","volume":"12","author":"Junren","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e921894","DOI":"10.12659\/MSM.921894","article-title":"Hirudin Reduces the Expression of Markers of the Extracellular Matrix in Renal Tubular Epithelial Cells in a Rat Model of Diabetic Kidney Disease Through the Hypoxia-Inducible Factor-1\u03b1 (HIF-1\u03b1)\/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway","volume":"26","author":"Pang","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.2147\/DDDT.S257613","article-title":"Hirudin Protects Against Kidney Damage in Streptozotocin-Induced Diabetic Nephropathy Rats by Inhibiting Inflammation via P38 MAPK\/NF-\u03baB Pathway","volume":"14","author":"Han","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"117779","DOI":"10.1016\/j.lfs.2020.117779","article-title":"Hirudin Reduces Nephropathy Microangiopathy in STZ-Induced Diabetes Rats by Inhibiting Endothelial Cell Migration and Angiogenesis","volume":"255","author":"Pang","year":"2020","journal-title":"Life Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10565-021-09622-z","article-title":"Hirudin Ameliorates Diabetic Nephropathy by Inhibiting Gsdmd-Mediated Pyroptosis","volume":"39","author":"Han","year":"2021","journal-title":"Cell Biol. Toxicol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"7291075","DOI":"10.1155\/2020\/7291075","article-title":"Hirudin Ameliorates Renal Interstitial Fibrosis via Regulating TGF- \u03b2 1\/Smad and NF- \u03ba B Signaling in UUO Rat Model","volume":"2020","author":"Yang","year":"2020","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Li, Y., Zhang, L., Xiong, W., Gao, X., Xiong, Y., and Sun, W. (2022). A Molecular Mechanism Study to Reveal Hirudin\u2019s Downregulation to PI3K\/AKT Signaling Pathway through Decreasing PDGFR\u03b2 in Renal Fibrosis Treatment. BioMed Res. Int., 2022.","DOI":"10.1155\/2022\/5481552"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"741801","DOI":"10.3389\/fphar.2021.741801","article-title":"Transcriptome-Based Network Analysis Reveals Hirudin Potentiates Anti-Renal Fibrosis Efficacy in UUO Rats","volume":"12","author":"Yu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1681\/ASN.2016070789","article-title":"Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent","volume":"28","author":"Sharma","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ddr.21932","article-title":"Hirudin Attenuates Puromycin Aminonucleoside-induced Glomerular Podocyte Injury by Inhibiting MAPK-mediated Endoplasmic Reticulum Stress","volume":"83","author":"Long","year":"2022","journal-title":"Drug Dev. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood-2006-03-008870","article-title":"Tissue Factor Deficiency and PAR-1 Deficiency Are Protective against Renal Ischemia Reperfusion Injury","volume":"109","author":"Sevastos","year":"2007","journal-title":"Blood"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"98","DOI":"10.7150\/jca.10496","article-title":"Fibronectin Matrix Formation Is a Prerequisite for Colonization of Kidney Tumor Cells in Fibrin","volume":"6","author":"Knowles","year":"2015","journal-title":"J. Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Chen, B., Ding, X., and Yang, Y. (2022). Hirudin Regulates Vascular Function in Chronic Renal Failure through Modulating Macrophage Polarization. BioMed Res. Int., 2022.","DOI":"10.1155\/2022\/6043698"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ddr.21773","article-title":"Hirudin Prevents Vascular Endothelial Cell Apoptosis and Permeability Enhancement Induced by the Serum from Rat with Chronic Renal Failure through Inhibiting RhoA\/ROCK Signaling Pathway","volume":"82","author":"Chen","year":"2021","journal-title":"Drug Dev. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/0886022X.2019.1583113","article-title":"Hirudin Ameliorates Immunoglobulin A Nephropathy by Inhibition of Fibrosis and Inflammatory Response","volume":"41","author":"Deng","year":"2019","journal-title":"Ren. Fail."},{"key":"ref_86","first-page":"586","article-title":"Exploring the Mechanism of Hirudin in the Treatment of Diabetic Kidney Disease Using Network Pharmacology Combined with Molecular Docking Verification","volume":"42","author":"Xinxin","year":"2022","journal-title":"J. Tradit. Chin. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1677\/joe.1.05647","article-title":"Vascular Endothelial Growth Factor Is Increased during Early Stage of Diabetic Nephropathy in Type II Diabetic Rats","volume":"183","author":"Cha","year":"2004","journal-title":"J. Endocrinol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1874364101307010004","article-title":"Diabetic Retinopathy and VEGF","volume":"7","author":"Gupta","year":"2013","journal-title":"Open Ophthalmol. J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: Advancements and Innovation in the Manufacturing Process","volume":"154","author":"Shah","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological Roles of MAPK Signaling Pathways in Human Diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta BBA Mol. Basis Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni748","article-title":"P38-Dependent Marking of Inflammatory Genes for Increased NF-\u03baB Recruitment","volume":"3","author":"Saccani","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 Cleaves Gasdermin D for Non-Canonical Inflammasome Signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.3389\/fphar.2022.998574","article-title":"NLRP3-Mediated Pyroptosis in Diabetic Nephropathy","volume":"13","author":"Wan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic Nephrotic Syndrome in Children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet"},{"key":"ref_95","first-page":"A7","article-title":"USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","volume":"2014","author":"System","year":"2013","journal-title":"Natl. Inst. Health Natl. Inst. Diabetes Dig. Dig. Kidney Dis."},{"key":"ref_96","first-page":"1","article-title":"Deaths: Final Data for 2010. National Vital Statistics Reports","volume":"61","author":"Murphy","year":"2013","journal-title":"Natl. Cent. Health Stat."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneph.2013.169","article-title":"The Podocyte Slit Diaphragm\u2014From a Thin Grey Line to a Complex Signalling Hub","volume":"9","author":"Grahammer","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1681\/ASN.2006060628","article-title":"Proteinuria with and without Renal Glomerular Podocyte Effacement","volume":"17","author":"Kalluri","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and Pathophysiology of Nephrotic Syndrome\u2013Associated Thromboembolic Disease","volume":"7","author":"Kerlin","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000045585","article-title":"Heparin Treatment Reduces Glomerular Injury in Rats with Adriamycin-Induced Nephropathy but Does Not Modify Tubulointerstitial Damage or the Renal Production of Transforming Growth Factor-Beta","volume":"84","author":"Baroni","year":"2000","journal-title":"Nephron"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejphar.2008.04.065","article-title":"Protective Effects of Antithrombin on Puromycin Aminonucleoside Nephrosis in Rats","volume":"589","author":"Yamashita","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_102","first-page":"5231","article-title":"Low but Sustained Coagulation Activation Ameliorates Glucose-Induced Podocyte Apoptosis: Protective Effect of Factor V Leiden in Diabetic Nephropathy","volume":"117","author":"Wang","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The Unfolded Protein Response: Controlling Cell Fate Decisions under ER Stress and Beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mam.2018.06.002","article-title":"Cellular and Molecular Mechanisms of Kidney Fibrosis","volume":"65","author":"Djudjaj","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI36183","article-title":"Biomarkers for Epithelial-Mesenchymal Transitions","volume":"119","author":"Zeisberg","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3892\/ijmm.2017.2931","article-title":"The Sirt1 Activator, SRT1720, Attenuates Renal Fibrosis by Inhibiting CTGF and Oxidative Stress","volume":"39","author":"Ren","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1681\/ASN.2004050425","article-title":"Role of Reactive Oxygen Species in TGF-\u03921-Induced Mitogen-Activated Protein Kinase Activation and Epithelial-Mesenchymal Transition in Renal Tubular Epithelial Cells","volume":"16","author":"Rhyu","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/ndt\/gfg398","article-title":"Thrombin Stimulates Production of Fibronectin by Human Proximal Tubular Epithelial Cells via a Transforming Growth Factor\u2014Dependent Mechanism","volume":"18","author":"Shirato","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: The Master Regulator of Fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"106249","DOI":"10.1016\/j.intimp.2020.106249","article-title":"Hirudin Improves Renal Interstitial Fibrosis by Reducing Renal Tubule Injury and Inflammation in Unilateral Ureteral Obstruction (UUO) Mice","volume":"81","author":"Xie","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad Pathways in TGF-\u03b2 Signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.soc.2013.06.008","article-title":"Targeting the PI3-Kinase\/Akt\/mTOR Signaling Pathway","volume":"22","author":"Hassan","year":"2013","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Jin, D., Kang, X., Zhou, R., Sun, Y., Lian, F., and Tong, X. (2021). Signaling Pathways Involved in Diabetic Renal Fibrosis. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.696542"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Hosohata, K., Harnsirikarn, T., and Chokesuwattanaskul, S. (2022). Ferroptosis: A Potential Therapeutic Target in Acute Kidney Injury. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126583"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5500\/wjt.v5.i2.52","article-title":"Update on Ischemia-Reperfusion Injury in Kidney Transplantation: Pathogenesis and Treatment","volume":"5","author":"Salvadori","year":"2015","journal-title":"World J. Transplant."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer Metastasis: Building a Framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1158\/0008-5472.CAN-07-6849","article-title":"Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton","volume":"68","author":"Barkan","year":"2008","journal-title":"Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.ajkd.2005.07.037","article-title":"Hemodialysis: Techniques and Prescription","volume":"46","author":"Ikizler","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.5301\/jva.5000665","article-title":"Patient Factors and Haemodialysis Arteriovenous Fistula Outcomes","volume":"18","author":"Masengu","year":"2017","journal-title":"J. Vasc. Access"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/VIT.VIT_9_19","article-title":"Molecular Targets for Improving Arteriovenous Fistula Maturation and Patency","volume":"2","author":"Gorecka","year":"2019","journal-title":"Vasc. Investig. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"11046","DOI":"10.1038\/s41598-019-47542-5","article-title":"Inhibition of the Akt1-mTORC1 Axis Alters Venous Remodeling to Improve Arteriovenous Fistula Patency","volume":"9","author":"Guo","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_122","first-page":"765","article-title":"Macrophage in Chronic Kidney Disease","volume":"9","author":"Guiteras","year":"2016","journal-title":"NDT Plus"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"G\u00f3mez, G.I., Velarde, V., and S\u00e1ez, J.C. (2019). Role of a RhoA\/ROCK-Dependent Pathway on Renal Connexin43 Regulation in the Angiotensin II-Induced Renal Damage. Int. J. Mol. Sci., 20.","DOI":"10.20944\/preprints201908.0044.v1"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Luvizotto, M.J., Menezes-Silva, L., Woronik, V., Monteiro, R.C., and C\u00e2mara, N.O.S. (2022). Gut-Kidney Axis in IgA Nephropathy: Role on Mesangial Cell Metabolism and Inflammation. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.993716"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00467-017-3652-1","article-title":"The Gut\u2013Kidney Axis in IgA Nephropathy: Role of Microbiota and Diet on Genetic Predisposition","volume":"33","author":"Coppo","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"ref_126","first-page":"846","article-title":"Heparin-Induced Thrombocytopenia with Thromboembolic Complications: Meta-Analysis of 2 Prospective Trials to Assess the Value of Parenteral Treatment with Lepirudin and Its Therapeutic aPTT Range","volume":"96","author":"Greinacher","year":"2000","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.beha.2004.02.002","article-title":"Bivalent Direct Thrombin Inhibitors: Hirudin and Bivalirudin","volume":"17","author":"Warkentin","year":"2004","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_128","first-page":"2617","article-title":"Antihirudin Antibodies Following Low-Dose Subcutaneous Treatment with Desirudin for Thrombosis Prophylaxis after Hip-Replacement Surgery: Incidence and Clinical Relevance","volume":"101","author":"Greinacher","year":"2003","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1161\/01.CIR.0000096056.37269.14","article-title":"Anaphylactic and Anaphylactoid Reactions Associated with Lepirudin in Patients with Heparin-Induced Thrombocytopenia","volume":"108","author":"Greinacher","year":"2003","journal-title":"Circulation"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1592\/phco.27.5.760","article-title":"Severe Anaphylactic Reaction after Repeated Intermittent Exposure to Lepirudin","volume":"27","author":"Veach","year":"2007","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1517\/14656566.3.6.777","article-title":"Bivalirudin: An Anticoagulant for Acute Coronary Syndromes and Coronary Interventions","volume":"3","author":"White","year":"2002","journal-title":"Expert Opin. Pharmacother."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/5\/1029\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:05:50Z","timestamp":1760105150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/5\/1029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":131,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["molecules29051029"],"URL":"https:\/\/doi.org\/10.3390\/molecules29051029","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]}}}